Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clexane for DVT Prevention Following EPS/RFA
NCT00232271Phase 4Terminated
- Sponsor
- Melbourne Health
- Start
- Aug 2005
- Primary completion
- Jan 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of enoxaparin in deep vein thrombosis (DVT), sponsored by Melbourne Health. Started Aug 2005; status: terminated.
02
Drugs
enoxaparin
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT00232271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00232271.